Patient info Open main menu

Ranolazine DR.Reddys 750 mg prolonged-release tablets – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
750 mg
Contains active substance:
ATC code:

Patient leaflet - Ranolazine DR.Reddys 750 mg prolonged-release tablets

1. What Ranolazine is and what it is used for

Ranolazine is a medicine used in combination with other medicines to treat angina pectoris, which is a chest pain or discomfort that you feel anywhere along the upper part of your body between your neck and upper abdomen, often brought on by exercise or too much activity.

You must talk to a doctor if you do not feel better or if you feel worse.

2. What you need to know before you take Ranolazine

Do not take use Ranolazine

  • if you are allergic to ranolazine or any of the other ingredients of this medicine (listed in section 6).
  • if you have severe kidney problems.
  • if you have moderate or severe liver problems.
  • if you are using certain medicines to treat bacterial infections (clarithromycin, telithromycin), fungal infections (itraconazole, ketoconazole, voriconazole, posaconazole), HIV infection (protease inhibitors), depression (nefazodone) or heart rhythm disorders (e.g. quinidine, dofetilide, or sotalol).

Warnings and precautions

Talk to your doctor before taking Ranolazine

  • if you have mild or moderate kidney problems.
  • if you have mild liver problems.
  • if you have ever had an abnormal electrocardiogram (ECG).
  • if you are elderly.
  • if you have low weight (60 kg or less).
  • if you have heart failure.

Your doctor may decide to give you a lower dose or take other precautions if any of these apply to you.

Other medicines and Ranolazine

Do not use the following medicines if you take Ranolazine

  • certain medicines to treat bacterial infections (clarithromycin, telithromycin), fungal infections (itraconazole, ketoconazole, voriconazole, posaconazole), HIV infection (protease inhibitors), depression (nefazodone), or heart rhythm disorders (e.g. quinidine, dofetilide, or sotalol).

Tell your doctor or pharmacist before you take Ranolazine if you use:

  • certain medicines to treat a bacterial infection (erythromycin), or a fungal infection (fluconazole), a medicine used to prevent rejection of a transplanted organ (ciclosporin), or if you are taking some heart tablets such as diltiazem or verapamil. These medicines may cause an increase in the number of side effects, such as dizziness, nausea, or vomiting, which are possible side effects of Ranolazine (see section 4). Your doctor may decide to give you a lower dose.
  • medicines to treat epilepsy or another neurologic disorder (e.g. phenytoin, carbamazepine, or phenobarbital); are taking rifampicin for an infection (e.g. tuberculosis); or are taking the herbal remedy St. John’s Wort, as these medicines may cause Ranolazine to be less effective.
  • heart medicines containing digoxin or metoprolol, as your doctor may want to change the dose of this medicine whilst you are taking Ranolazine.
  • certain medicines to treat allergies (e.g. terfenadine, astemizole, mizolastine), heart rhythm disorders (e.g. disopyramide, procainamide), and depression (e.g. imipramine, doxepin, amitriptyline), as these medicines may affect your ECG.
  • certain medicines to treat depression (bupropion), psychosis, HIV infection (efavirenz), or cancer (cyclophosphamide).
  • certain medicines to treat high levels of cholesterol in the blood (e.g. simvastatin, lovastatin, atorvastatin). These medicines may cause muscle pain and muscle injury. Your doctor may decide to change the dose of this medicine while you are taking Ranolazine.
  • certain medicines used to prevent transplanted organ rejection (e.g. tacrolimus, ciclosporin, sirolimus, everolimus) as your doctor may decide to change the dose of this medicine while you are taking Ranolazine. Tell your doctor or pharmacist if you are taking have recently taken or might take any other medicines.

Ranolazine with food and drink

Ranolazine can be taken with or without food. While being treated with this medicine, you should not drink grapefruit juice.

Pregnancy

You should not take this medicine if you are pregnant unless your doctor has advised you to do so.

Breastfeeding

You should not take this medicine if you are breastfeeding. Ask your doctor for advice if you are breastfeeding. If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Driving and using machines

No studies on the effects of this medicine on the ability to drive and use machines have been performed. Ask your doctor for advice about driving or using machines.

Ranolazine may cause side effects such as dizziness (common), blurred vision (uncommon), confusional state (uncommon), hallucination (uncommon), double vision (uncommon), coordination problems (rare), that may affect your ability to drive or use machines. If you experience these symptoms, do not drive or operate machinery until they have resolved completely.

Ranolazine Dr. Reddy’s 750 mg prolonged-release tablets contains lactose monohydrate. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.

This medicine contains less than 1 mmol sodium (23 mg) per prolonged-release tablet, that is to say essentially ‘sodium-free’.

3. How to take Ranolazine

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

Always swallow the tablets whole with water. Do not crush, suck, or chew the tablets or break them in half, as this might affect the way the medicine is released from the tablets into your body.

The starting dose for adults is one 375 mg tablet twice a day. After 2−4 weeks, your doctor may increase the dose to get the right effect. The maximum dose of Ranolazine is 750 mg twice a day.

It is important that you tell your doctor if you get side effects such as dizziness or feeling or being sick. Your doctor may lower your dose or, if this is not sufficient, stop treatment with Ranolazine.

Use in children and adolescents

Children and adolescents under 18 years old should not take this medicine.

If you take more Ranolazine than you should

If you accidentally take too many Ranolazine tablets or take a higher dose than recommended by your doctor, it is important that you tell your doctor at once. If you cannot contact your doctor, go to the nearest accident and emergency department. Take along any tablets that are left, including the container and the carton, so that the hospital staff can easily tell what you have taken.

If you forget to take Ranolazine

If you forget to take a dose, take it as soon as you remember unless it is nearly time (less than 6 hours) to take your next dose. Do not take a double dose to make up for a forgotten dose.

If you have any further questions on the use of this medicine, ask your doctor, or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

You should stop taking this medicine and see your doctor immediately if you experience the following symptoms of angioedema, which is a rare condition but can be severe:

  • swollen face, tongue, or throat
  • difficulty swallowing
  • hives or difficulty breathing

Tell your doctor if you experience common side effects such as dizziness or feeling sick or vomiting. Your doctor may lower your dose or stop treatment with this medicine.

Other side effects you may experience include the following:

Common side effects (occur in 1 to 10 users in 100) are:

  • Constipation
  • Dizziness
  • Headache
  • Feeling sick, vomiting
  • Feeling weak

    Package leaflet: Information for the patient

    Ranolazine Dr. Reddy’s 375 mg, 500 mg, 750 mg Prolonged-release tablets ranolazine

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor. This includes any possible side effects not listed in this leaflet. See section 4.

    xxxxxxx/xxx

10mm 10mm

180mm

8mm

Version No: v1.5

Submission

Brand: Dr. Reddy’s

Country: UK

Product Name: Ranolazine

Strength: 375 / 500 / 500 mg

Form: Prolonged-release tablets

Component: Leaflet

Pack Size: N/A

Date Created: 14 Feb 2021

Date Modified: 17 Sepl 2024

Project: CC1000132685

Previous DR No: DR001056P-7C

Previous Material

Number:

N/A

Commercial

DR No: DRxxxxx

Material Code: N/A

Third Party

Material Code:

DRxxxxxx

Process Black

Dr. Reddy’s Laboratories (UK) Ltd, 410 Cambridge Science Park, Milton Road, Cambridge,

CB4 0PE, United Kingdom

Please note that any low resolution paper Canon colour copies associated with this job should be referred to for content, layout and colour separation only.

Uncommon side effects (occur in 1 to 10 users in 1,000) are:

  • Altered sensation
  • Anxiety, difficulty sleeping, confusional state, hallucination
  • Blurred vision, visual disturbance
  • Changes in sensation (touch or taste), tremor, feeling tired or sluggish, sleepiness or drowsiness, faint or fainting, dizziness upon standing
  • Dark urine, blood in urine, difficulty urinating
  • Dehydration
  • Difficulty breathing, cough, nose bleed
  • Double vision
  • Excessive sweating, itching
  • Feeling swollen or bloated
  • Hot flushes, low blood pressure
  • Increases in a substance called creatinine or increases in urea in your blood, increase in blood platelets or white blood cells, changes in ECG heart tracing
  • Joint swelling, pain in extremity
  • Loss of appetite and/or weight loss
  • Muscle cramp, muscle weakness
  • Ringing in the ears and/or feeling a spinning sensation
  • Stomach pain or discomfort, indigestion, dry mouth, or wind

Rare side effects (occur in 1 to 10 users in 10,000) are:

  • A lack of ability to urinate
  • Abnormal laboratory values for liver
  • Acute kidney failure
  • Change in sense of smell, numbness in mouth or lips, impaired hearing
  • Cold sweat, rash
  • Coordination problems
  • Decrease in blood pressure upon standing
  • Decreased or loss of consciousness
  • Disorientation
  • Feeling of coldness in hands and legs
  • Hives, allergic skin reaction
  • Impotence
  • Inability to walk due to imbalance
  • Inflammation of pancreas or intestine
  • Loss of memory
  • Throat tightness
  • Low level of sodium in the blood (hyponatremia) which can cause tiredness and confusion, muscle twitching, cramps, and coma.

Not known side effects (frequency cannot be estimated from the available data) are:

  • Myoclonus

Reporting of side effects

If you get any side effects, talk to your doctor or, pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme website www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Ranolazine

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on each blister strip of tablets and on the outside of the carton and bottle after EXP. The expiry date refers to the last day of that month.

This medicinal product does not require any special storage conditions.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Ranolazine prolonged-release tablet contains

The active substance is ranolazine. Each tablet contains 375 mg, 500 mg, or 750 mg of ranolazine. The other ingredients are: methacrylic Acid – ethyl acrylate copolymer (1:1), microcrystalline cellulose, hypromellose, sodium hydroxide and magnesium stearate.

Depending on the tablet strength, the tablet coatings also contain:

375 mg tablet: hypromellose , titanium dioxide, macrogol, polysorbate 80 and FD&C Blue#2/Indigotine Aluminum Lake

500 mg tablet: polyvinyl alcohol, titanium dioxide, macrogol, talc, yellow iron oxide and red iron oxide

750 mg tablet: hypromellose, lactose monohydrate, titanium dioxide, triacetin, yellow iron oxide , FD&C Blue#1/FCF Fast Blue Aluminium Lake

What Ranolazine prolonged-release tablet looks like and contents of the pack

Ranolazine prolonged-release tablets are oval shaped tablets.

The 375 mg tablets are pale blue and are engraved with 375 on one side. The size is 15 x 8 mm approximately. The 500 mg tablets are light orange and are engraved with 500 on one side. The size is 17 x 8 mm approximately. The 750 mg tablets are pale green and are engraved with 750 on one side. The size is 19 x 9 mm approximately.

This medicine is supplied in carton boxes containing 30, 60, or 100 tablets in blisters.

Not all pack-sizes may be marketed.

Marketing Authorisation Holder

Dr. Reddy’s Laboratories (UK) Ltd.,

410 Cambridge Science Park, Milton Road,

Cambridge, CB4 0PE,

United Kingdom

Manufacturer

ELPEN Pharmaceutical Co. Inc.

Marathonos Ave. 95, Pikermi Attiki, 19009, Greece

This leaflet was last revised in September 2024.

DRxxxxxxx 10mm 10mm

180mm

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 08553/0749

Last revision stated in the text: September 2024 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Ranolazine DR.Reddys 750 mg prolonged-release tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Ranolazine
Strength 750 mg
Pharmaceutical form Modified-release tablet
Pale green oval-shaped tablet engraved with 750 on one side and with dimensions 19 x 9 mm approximately.
How is it taken Oral
Excipients Methacrylic acid-ethyl acrylate copolymer (1:1), Microcrystalline cellulose, Hypromellose, Sodium hydroxide, Magnesium stearate, Lactose monohydrate, Titanium dioxide, Triacetin (E1518), Iron oxide yellowFD&C Blue#1/FCF Fast Blue Aluminium Lake (E133)
Pack sizes 60 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 5 years
Storage This medicinal product does not require any special storage conditions.
Drug group (ATC) Other cardiac preparations
  1. C Cardiovascular system drugs
    1. C01 Cardiac therapy drugs
      1. C01E Other cardiac preparations
        1. C01EB Other plain cardiac preparations
          1. C01EB18 ranolazine
Marketing authorisation PL 08553/0749 (first authorised 1 August 2024)
Marketing authorisation holder Dr. Reddy’s Laboratories (UK) Ltd.
Codes GTIN 5036072008519 · BNF 02060300

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.